Our research, and the technology we acquire are anchored by our relationships with synergistic partners and product-specific commercialization strategies. From the point of product or technology conception, or through acquisition, development and commercialization, we expect to have strategic partners, joint ventures or licensing arrangements in place for many of our products in order to sustain revenue attainment.
This model provides distinct advantages to our stockholders, including:
(i) more efficient and effective research and
(ii) quicker time to market with a distinguished go-
(iii) value-added growth for the Company and a
safe harbor for shareholder investments.
This is achieved through long-term projects and agreements that deliver diversified, enduring revenue streams for the company and support solid, sustainable investment yields. Our overall objective is to redefine “Blue Chip” in investing vocabulary.